Table 3.
The relationship of Vitamin D2 and D3 to diabetes complications in the cohort of subjects with Type 2 Diabetes (n = 274). The actual number of diabetic patients per measure are detailed and may not add up to 274 due to missing values when the vitamin D levels were at the lower limit of detection then as they could not be accurately determined they were excluded from the analysis
| 25(OH)D2 (ng/dl) median (range) | P-value | 25(OH)D3 (ng/dl) median (range) | P-value | |
|---|---|---|---|---|
| Diabetes | ||||
| No n = 222 | 7.85 (20.5) | < 0.001 | 8.95 (9.31) | < 0.001 |
| Yes n = 274 | 20.2 (21.1) | 6.21 (10.53) | ||
| Gender | ||||
| Male n = 110 | 14.07 (21.69) | < 0.001 | 8.26 (11.01) | < 0.001 |
| Female n = 164 | 23.06 (21.31) | 4.52 (7.44) | ||
| Hypertension | ||||
| No n = 96 | 13.82 (22.14) | < 0.001 | 6.39 (10.39) | 0.612 |
| Yes n = 163 | 21.63 (20.57) | 6.06 (10.61) | ||
| Dyslipidemia | ||||
| No n = 71 | 11.80 (18.58) | < 0.001 | 6.86 (10.63) | 0.061 |
| Yes n = 188 | 21.58 (18.95) | 5.59 (9.0) | ||
| Diab_Retinopathy | ||||
| No n = 182 | 19.53 (20.28) | 0.445 | 6.25 (8.96) | 0.014 |
| Yes n = 77 | 20.65 (21.78) | 7.98 (11.76) | ||
| Diab_Neuropathy | ||||
| No n = 209 | 19.42 (20.99) | 0.517 | 6.25 (10.66) | 0.74 |
| Yes n = 50 | 21.52 (19.59) | 6.18 (7.79) | ||